Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1680

1.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
2.

Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.

Haug U, Hundt S, Brenner H.

Am J Gastroenterol. 2010 Mar;105(3):682-90. doi: 10.1038/ajg.2009.668. Epub 2009 Dec 1.

PMID:
19953091
3.

A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Ann Intern Med. 2007 Feb 20;146(4):244-55.

PMID:
17310048
4.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
5.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
6.

Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Aliment Pharmacol Ther. 2009 Apr 15;29(8):906-17. doi: 10.1111/j.1365-2036.2009.03946.x.

7.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
8.
9.

Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.

Hoepffner N, Shastri YM, Hanisch E, Rösch W, Mössner J, Caspary WF, Stein J.

Aliment Pharmacol Ther. 2006 Jan 1;23(1):145-54.

10.

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.

Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS.

Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.

PMID:
20502450
11.

A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC.

Am J Gastroenterol. 2000 May;95(5):1331-8.

PMID:
10811348
12.

Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.

Mulder SA, van Leerdam ME, van Vuuren AJ, Francke J, van Toorenenbergen AW, Kuipers EJ, Ouwendijk RJ.

Eur J Gastroenterol Hepatol. 2007 Oct;19(10):878-82.

PMID:
17873612
13.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
14.

Summaries for patients. Immunochemical fecal occult blood tests.

[No authors listed]

Ann Intern Med. 2009 Feb 3;150(3):I34. No abstract available.

PMID:
19189901
15.

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK.

Aliment Pharmacol Ther. 2003 Nov 1;18(9):941-6.

16.

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.

Graser A, Stieber P, Nagel D, Schäfer C, Horst D, Becker CR, Nikolaou K, Lottes A, Geisbüsch S, Kramer H, Wagner AC, Diepolder H, Schirra J, Roth HJ, Seidel D, Göke B, Reiser MF, Kolligs FT.

Gut. 2009 Feb;58(2):241-8. doi: 10.1136/gut.2008.156448. Epub 2008 Oct 13.

PMID:
18852257
17.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
18.

Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y.

Aliment Pharmacol Ther. 2009 Feb 15;29(4):450-7. doi: 10.1111/j.1365-2036.2008.03898.x. Epub 2008 Nov 17.

19.

Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.

Ou CH, Kuo FC, Hsu WH, Lu CY, Yu FJ, Kuo CH, Wang JY, Wu MT, Shiea J, Wu DC, Hu HM.

J Dig Dis. 2013 Sep;14(9):474-83. doi: 10.1111/1751-2980.12077.

PMID:
23701988
20.

The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer.

Wong CK, Fedorak RN, Prosser CI, Stewart ME, van Zanten SV, Sadowski DC.

Int J Colorectal Dis. 2012 Dec;27(12):1657-64. doi: 10.1007/s00384-012-1518-3. Epub 2012 Jun 14.

PMID:
22696204

Supplemental Content

Support Center